Evidence map›Paper›PMID 40342844›Full record

ArticleImmune network2025

Novel

Kornvalee Meesilpavikkai, Kasiphak Kaikaew, Zijun Zhou, Virgil A S H Dalm, Fabian M P Kaiser, Christopher Schliehe, Sigrid M A Swagemakers, Peter J van der Spek, Benjamin Schrijver, Pamela Vasic and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Immune network, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. STAT3 SH2 Domain Aspartic Acid 661 Mutations Activate Immune Gene Programs.Journal of cellular and molecular medicine · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Kornvalee MeesilpavikkaiLaboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0002-3502-6345
Kasiphak KaikaewCenter of Excellence in Alternative and Complementary Medicine for Gastrointestinal and Liver Diseases, Department of Physiology, Faculty of Medicine, Chulalongkorn University, Bangkok10330, Thailand.ORCID https://orcid.org/0000-0002-1790-1839
Zijun ZhouLaboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0001-8761-7828
Virgil A S H DalmLaboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0001-5945-4435
Fabian M P KaiserLaboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0002-0335-2859
Christopher SchlieheDepartment of Immunology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0002-1923-8620
Sigrid M A SwagemakersDepartment of Pathology and Bioinformatics, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0003-4339-8189
Peter J van der SpekDepartment of Pathology and Bioinformatics, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0002-2203-0652
Benjamin SchrijverLaboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0002-6427-6765
Pamela VasicLaboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
Maaike de BieLaboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
Marleen BakkerDepartment of Pulmonary Medicine, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0001-6965-5767
Chiara MilaneseDepartment of Molecular Genetics, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0001-8696-2603
Pier G MastroberardinoDepartment of Molecular Genetics, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0003-2364-4258
Nattiya HirankarnCenter of Excellence in Immunology and Immune-mediated Diseases, Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok10330, Thailand.ORCID https://orcid.org/0000-0003-2224-6856
Narissara SuratannonDivision of Allergy and Immunology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok10330, Thailand.ORCID https://orcid.org/0000-0003-1182-3611
Hanna IJspeertLaboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0002-7061-5321
Willem A DikLaboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0001-5235-3156
P Martin van HagenLaboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The STAT3 is an important regulator in a wide range of different cell types. Human

Indexed as

Cell respirationElectrophoretic mobility shift assayGain of function mutationImmune system disorderNuclear transport

Identifiers

PMID40342844
PMCPMC12056293

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.